|
|
Volumn 22, Issue 4, 2004, Pages 364-365
|
|
Purchase of Aton spotlights HDAC inhibitors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
HISTONE DEACETYLASE;
ARTICLE;
BIOLOGICAL MODEL;
BIOTECHNOLOGY;
CHROMATIN;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG INDUSTRY;
HUMAN;
METABOLISM;
METHODOLOGY;
NEOPLASM;
ANTINEOPLASTIC AGENTS;
BIOTECHNOLOGY;
CHROMATIN;
DRUG DESIGN;
DRUG INDUSTRY;
ENZYME INHIBITORS;
HISTONE DEACETYLASES;
HUMANS;
MODELS, BIOLOGICAL;
NEOPLASMS;
|
|
EID: 7244221565
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0404-364 Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|
